In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.

We investigated the activity of benzoxazinorifamycin (KRM-1648) against several drug-susceptible and multidrug-resistant strains of tubercle bacilli. Since KRM-1648 is a rifamycin derivative, we included some strains of Mycobacterium tuberculosis resistant to rifampin (RIF) among the multidrug-resis...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Luna-Herrera, J, Reddy, M V, Gangadharam, P R
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1995
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162557/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726512/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.440
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!